Beta-hCG (Cancer Marker) Test
About Beta-hCG (Cancer Marker) Test
| Field | Value |
|---|---|
| Also Known As | β-hCG, Beta-HCG, Human Chorionic Gonadotropin (Tumour Marker), Quantitative hCG, HCG Beta Subunit Test |
| Sample Type | Serum (venous blood) |
| Fasting Required | No fasting required |
| Report Time | Within 1 day |
| Recommended For | Males and non-pregnant females being evaluated for certain cancers; used for treatment monitoring |
| Price | Starting at ₹650 |
What Is a Beta-hCG (Cancer Marker) Test?
The beta-hCG test measures the level of human chorionic gonadotropin (hCG) in the blood. hCG is a hormone that, in this context, is used as a tumour marker to support cancer diagnosis and monitoring. When ordered as a cancer marker, this test is intended for males and non-pregnant females. A blood sample drawn from a vein in the arm is used for the test.
What Does a Beta-hCG (Cancer Marker) Test Measure?
This test measures the specific level of beta-hCG in the serum. The following table explains what the result indicates in an oncology setting.
| Component | What It Tells Your Doctor |
|---|---|
| Beta-hCG level | Whether hCG is present above the expected range in a non-pregnant individual, which may point to certain tumours |
| Trend over time | Whether levels are rising, stable, or falling, which helps assess treatment response or recurrence |
Why Is a Beta-hCG (Cancer Marker) Test Done?
A doctor may order this test for several reasons, from initial investigation of suspicious symptoms to ongoing monitoring during cancer treatment.
Common Symptoms That May Require This Test
The following symptoms may prompt a doctor to request this test:
- A lump or swelling in the testicular area
- Unexplained or abnormal vaginal bleeding in non-pregnant women
- Persistent pelvic pain with no clear cause
- Unexplained weight loss
- Gynaecomastia (breast tissue enlargement in males)
- A persistent cough that does not resolve, which may suggest lung involvement
Conditions This Test Can Help Detect
This test can support the investigation of several conditions. These include:
- Seminomatous and non-seminomatous testicular germ cell tumours
- Ovarian germ cell tumours
- Gestational trophoblastic disease (GTD), including hydatidiform mole and choriocarcinoma
- Certain other cancers, including those affecting the breast, liver, lungs, pancreas, cervix, and stomach, where hCG may be produced at lower levels
- Non-cancerous conditions such as cirrhosis, duodenal ulcer, and inflammatory bowel disease, which may also show mildly elevated levels
Beta-hCG (Cancer Marker) Test for Chronic Disease Monitoring
This test is widely used to track how well treatment is working. After successful treatment of an hCG-producing tumour, levels should decline with an apparent half-life of 24 to 36 hours and eventually return to the normal range. If levels do not fall as expected, this may suggest residual tumour tissue. For gestational trophoblastic neoplasia, this quantitative hCG test is the primary tool used throughout surveillance, treatment, and follow-up.
How to Prepare and What to Expect
No special preparation is needed for this test. However, a few simple steps will help ensure an accurate result.
Do You Need to Fast?
No, fasting is not required before the beta-hCG (cancer marker) test. You can eat and drink as normal before your appointment.
Practical Tips Before Your Test
The following steps will help your test go smoothly:
- Bring a detailed clinical history, including your symptoms, previous test results, and any cancer treatment history, as this is required for the test.
- If you are taking high-dose biotin supplements (more than 5 mg per day), stop them at least 8 hours before the test, as biotin can interfere with results.
- Mention to your doctor all medications you are currently taking, especially fertility treatments that contain hCG.
- Wear clothing with sleeves that roll up easily to allow access to your arm.
Step-by-Step Procedure
Here is what to expect during your sample collection:
- A trained phlebotomist will ask you to sit comfortably and roll up your sleeve.
- A small needle is used to draw blood from a vein in your arm. The process usually takes less than five minutes.
- You may feel a brief sting when the needle is inserted. This is normal and temporary.
- The blood sample is collected into a serum gel tube and labelled with your details.
- The sample is stored at the correct temperature and sent to the laboratory.
- The sample is tested using an enzyme immunoassay (EIA) method, and your report is ready within 1 day.
Factors That Can Affect Accuracy
Several factors can influence the accuracy of the result. These include:
- High-dose biotin supplementation taken close to the time of the test
- Fertility medications containing hCG
- Heterophile antibody interference, which is a rare cause of false-positive results
- Marijuana use, which may mildly affect levels
- The timing of the sample in relation to your treatment cycle
Understanding Your Beta-hCG (Cancer Marker) Test Results
Your results should always be reviewed with your treating doctor, who will consider them alongside your clinical history, imaging findings, and overall health.
| Parameter | Normal Range | Unit |
|---|---|---|
| Beta-hCG (males) | Less than 2 | mIU/mL |
| Beta-hCG (non-pregnant females) | Less than 5 | mIU/mL |
| Beta-hCG (postmenopausal women) | 5.0 to 25.0 (mildly elevated range) | mIU/mL |
| Beta-hCG (tumour marker threshold) | Less than 2 | mIU/mL |
These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
Results During Special Conditions
A few specific situations can affect how results are interpreted:
- Postmenopausal women may have mildly elevated levels between 5.0 and 25.0 mIU/mL, which does not automatically indicate cancer.
- Non-cancerous conditions such as hypogonadism or marijuana use may also cause mild elevations.
- In cases of gestational trophoblastic disease, certain tumours may produce a form of hCG with a longer half-life; if the apparent half-life is more than 3 days after treatment, this may suggest residual tumour tissue is still present.
How to Maintain Healthy Levels
The following general wellness practices support your overall health, particularly during and after cancer treatment:
- Attend all scheduled follow-up appointments so that serial beta-hCG results can be tracked over time.
- Report any new or worsening symptoms to your oncologist promptly.
- Maintain a balanced diet, adequate rest, and regular light activity to support general wellbeing during treatment.
Lupin Diagnostics Beta-hCG (Cancer Marker) Test Price and Home Collection
The beta-hCG (cancer marker) test is available at Lupin Diagnostics starting at ₹650, with home collection available across cities in India. The table below lists approximate prices by city.
| City | Approximate Price (₹) |
|---|---|
| BHOPAL | 650 |
| CHENNAI | 650 |
| HYDERABAD | 650 |
| KOLKATA | 650 |
| NAVI MUMBAI | 650 |
| PUNE | 650 |
Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
Follow these steps to book your test:
- Select the beta-hCG (cancer marker) test on the Lupin Diagnostics website.
- Choose your city and preferred time slot.
- Opt for home sample collection by a certified phlebotomist, or visit your nearest Lupin Diagnostics centre.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Home Collection
Lupin Diagnostics offers home sample collection for the beta-hCG test across multiple cities in India. All samples are processed in NABL-accredited laboratories by qualified professionals. Your digital report is delivered securely to your email or WhatsApp once ready.
Frequently Asked Questions
This test is used to support the diagnosis and monitoring of certain cancers, including testicular germ cell tumours, ovarian germ cell tumours, and gestational trophoblastic disease. It is used alongside clinical evaluation and other diagnostic procedures, not as a standalone diagnostic tool.
No, fasting is not required. You can eat and drink normally before the test. If you take high-dose biotin supplements, stop them at least 8 hours before your appointment.
No. While the beta-hCG (cancer marker) test is a valuable aid in cancer management, it cannot confirm or rule out cancer by itself. A definitive cancer diagnosis requires tissue biopsy and other investigations alongside clinical assessment.
The frequency depends on your treatment protocol and clinical response. In many cases, levels are monitored every two to four weeks during treatment and follow-up. Your doctor will advise the appropriate schedule based on your condition.
Yes. Mildly elevated levels may occur in conditions such as liver cirrhosis, duodenal ulcer, and inflammatory bowel disease. This is why results are always interpreted in the context of your full clinical picture.
If levels do not decline as expected after treatment, with the expected half-life being 24 to 36 hours, this may suggest residual or recurrent disease. Your doctor will advise on further evaluation in such cases.
Yes. Both tests measure the same hormone, but they serve different purposes. The cancer marker version is specifically used in oncology for males and non-pregnant females. Results from this test are not interpretable as a tumour marker in pregnant women.
Beta-hCG (Cancer Marker) Test: Booking, Price, and Results
